AZD6738

A Phase Ib Study of AZD6738 for Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia Progressing on Front-Line Therapy

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1
Enrollment
52 patients (estimated)
Sponsors
Massachusetts General Hospital
Collaborators
AstraZeneca
Tags
Kinase Inhibitor
Trial Type
Treatment
Last Update
3 months ago
SparkCures ID
1560
NCT Identifier
NCT03770429

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.